Moderna says patent ruling not to affect COVID-19 vaccine development
Moderna Inc said on Friday its formula used in developing a COVID-19 vaccine was not covered under patents owned by Arbutus Biopharma.
Moderna shares were up slightly in extended trading, while Arbutus shares closed down 20% on Friday. Photo: Reuters